ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

XENE Xenon Pharmaceuticals Inc

43.19
-0.56 (-1.28%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Xenon Pharmaceuticals Inc XENE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.56 -1.28% 43.19 07:12:54
개장가 저가 고가 종가 전일 종가
43.87 42.67 44.3672 43.19 43.75
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
16/04/202421:30GLOBEXenon Pharmaceuticals Showcases XEN1101 at the American..
05/04/202405:01GLOBEXenon Pharmaceuticals to Present at the 23rd Annual Needham..
13/03/202405:01GLOBEXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
09/03/202408:47EDGAR2Form 144 - Report of proposed sale of securities
09/03/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:27EDGAR2Form 8-K - Current report
08/03/202409:04EDGAR2Form 144 - Report of proposed sale of securities
08/03/202409:03EDGAR2Form 144 - Report of proposed sale of securities
06/03/202406:01GLOBEXenon Pharmaceuticals to Present at Leerink Partners Global..
01/03/202406:10EDGAR2Form 8-K - Current report
01/03/202406:01GLOBEXenon Pharmaceuticals Reports Fourth Quarter and Full Year..
23/02/202406:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
14/02/202423:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202422:00GLOBEXenon Pharmaceuticals Outlines Key Milestone Opportunities..
03/01/202422:30GLOBEXenon Pharmaceuticals to Present at the 42nd Annual J.P...
03/01/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:16GLOBEXenon Pharmaceuticals Announces Closing of $345.0 Million..
03/12/202302:01GLOBEXenon Pharmaceuticals Provides Updates on Neurology Pipeline..
01/12/202306:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202306:15EDGAR2Form 8-K - Current report
30/11/202312:51GLOBEXenon Pharmaceuticals Announces Pricing of Upsized $300.0..
30/11/202307:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/11/202306:03GLOBEXenon Pharmaceuticals Announces Proposed Public Offering
27/11/202321:03EDGAR2Form 8-K - Current report
27/11/202321:00GLOBEXenon Pharmaceuticals Announces Topline Results from Phase 2..
10/11/202306:06EDGAR2Form 8-K - Current report
10/11/202306:03GLOBEXenon Pharmaceuticals Provides Update on Partnered Program..
09/11/202306:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:11EDGAR2Form 8-K - Current report
09/11/202306:01GLOBEXenon Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202305:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
10/10/202305:15GLOBEXenon Pharmaceuticals Announces Publication of Results from..
06/10/202321:30GLOBEXenon Pharmaceuticals to Present at Jefferies Inaugural..
15/09/202305:01GLOBEXenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual..
13/09/202305:30GLOBEXenon Pharmaceuticals Announces Upcoming Investor Webinar..
04/09/202321:30GLOBEXenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at..
01/09/202305:01GLOBEXenon Pharmaceuticals to Present at the Wells Fargo 2023..
11/08/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202308:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/08/202307:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202307:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/08/202305:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:16EDGAR2Form 8-K - Current report
10/08/202305:01GLOBEXenon Pharmaceuticals Reports Second Quarter 2023 Financial..
09/08/202305:07EDGAR2Form 8-K - Current report
09/08/202305:01GLOBEXenon Pharmaceuticals Expands Leadership on its Board of..
03/08/202305:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
07/06/202305:35GLOBEXenon Pharmaceuticals to Present at the Goldman Sachs 44th..

최근 히스토리

Delayed Upgrade Clock